02.24.26 -- Optimizing CGT Development: Data-Driven, Platform-Based Solutions

A CGT contract development and manufacturing organization, together with an independent technology center focused on advancing the CGT sector, announced a collaboration to develop delivery technologies aimed at enabling more robust processes.

Viral vectors are the indispensable backbone of genetic medicine. Learn the fundamental trade-offs and manufacturing strategies for large-scale production of AAV and lentiviral delivery systems.

Achieve faster AAV gene therapy progress by adopting a unified platform for manufacturing. Accelerate your program to GMP readiness with up to 9x higher titers and robust, high-quality full capsid yields.

With 30+ years of experience in viral vector development and manufacturing, we bring unmatched expertise as your trusted CDMO for AAV. From plasmids to fill/finish and advanced analytics, we provide true end-to-end support.

A new platform approach streamlines lentiviral vector design and manufacturing, boosting yield, lowering costs, and accelerating access to gene‑modified cell therapies worldwide.

Downstream AAV manufacturing remains a critical bottleneck, and overcoming it requires true platforming that couples standardized processes with scalable, data-driven CMC systems to improve speed, cost, and program viability.

Risk-based quality systems, proactive problem-solving, and collaborative client relationships drive operational excellence, supported by digital QMS tools for compliance, deviation management, and continuous improvement in biomanufacturing.

Our mission is clear: to help sponsors reduce costs, shorten timelines, and de-risk development, so they can achieve milestones, secure investments, and advance therapies.

Fast-track your Gene Therapies from cutting-edge process development to commercial success with advanced viral vector manufacturing solutions!

Our expanded biologics services and technologies encompass the entire RNA development and manufacturing value chain, helping to deliver your innovation to patients seamlessly.

To ensure the success of gene therapy, learn why it is crucial to partner with a CRO that can navigate the challenges of viral vector development and testing.